• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单剂量普兰林肽对胰岛素依赖型糖尿病男性患者两餐胃排空的影响。

The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM.

作者信息

Kong M F, Stubbs T A, King P, Macdonald I A, Lambourne J E, Blackshaw P E, Perkins A C, Tattersall R B

机构信息

Department of Diabetes, University Hospital, Queen's Medical Centre, Nottingham, UK.

出版信息

Diabetologia. 1998 May;41(5):577-83. doi: 10.1007/s001250050949.

DOI:10.1007/s001250050949
PMID:9628276
Abstract

In a previous study we have shown that an intravenous infusion of pramlintide (an analogue of human amylin) delayed gastric emptying, but the dose of pramlintide was supraphysiological in relation to the amylin response to food in non-diabetic subjects. The purpose of this study was to examine the dose response relationship of subcutaneous injections of pramlintide on gastric emptying and to determine whether administration of the drug before one meal has an impact on the subsequent meal. Eleven men with insulin-dependent diabetes mellitus were studied in a double-blind, randomised, four-way crossover design. None had autonomic neuropathy. Euglycaemia was maintained overnight before the study day. At -30 min the patients self-injected their usual morning insulin and at -15 min they injected the study drug (either placebo or 30, 60 or 90 microg pramlintide) subcutaneously. At 0 min they ate a standard meal consisting of a pancake, labelled with 99mTc, and a milkshake containing 3-ortho-methylglucose (3-OMG). Gastric emptying images were obtained for the next 8 h. At 240 min the subjects ate a similar meal, but on this occasion the pancake was labelled with (111)In. All three doses of pramlintide delayed emptying of the solid component of the first meal (p < 0.004) with no significant difference between the drug doses. There were no differences between placebo and pramlintide after the second meal. All three doses of pramlintide resulted in a prolongation in the time to peak plasma 3-OMG level (p < 0.0001) after the first meal but there was no difference after the second meal.

摘要

在之前的一项研究中,我们已经表明静脉输注普兰林肽(一种人胰淀素类似物)会延迟胃排空,但相对于非糖尿病受试者对食物的胰淀素反应而言,普兰林肽的剂量是超生理剂量。本研究的目的是研究皮下注射普兰林肽对胃排空的剂量反应关系,并确定在一餐前给药是否会对随后一餐产生影响。我们采用双盲、随机、四交叉设计对11名胰岛素依赖型糖尿病男性患者进行了研究。所有患者均无自主神经病变。在研究日之前的夜间维持血糖正常。在 -30分钟时,患者自行皮下注射其常规的早晨胰岛素,在 -15分钟时,他们皮下注射研究药物(安慰剂或30、60或90微克普兰林肽)。在0分钟时,他们进食一顿标准餐,包括用99mTc标记的薄煎饼和含有3-邻甲基葡萄糖(3-OMG)的奶昔。在接下来的8小时内获取胃排空图像。在240分钟时,受试者进食类似的一餐,但此次薄煎饼用(111)In标记。所有三种剂量的普兰林肽均延迟了第一餐固体成分的排空(p < 0.004),各药物剂量之间无显著差异。第二餐后安慰剂和普兰林肽之间没有差异。所有三种剂量的普兰林肽在第一餐后均导致血浆3-OMG水平达到峰值的时间延长(p < 0.0001),但第二餐后没有差异。

相似文献

1
The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM.单剂量普兰林肽对胰岛素依赖型糖尿病男性患者两餐胃排空的影响。
Diabetologia. 1998 May;41(5):577-83. doi: 10.1007/s001250050949.
2
Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM.注射普兰林肽(一种人胰淀素类似物)可延缓胰岛素依赖型糖尿病男性患者的胃排空。
Diabetologia. 1997 Jan;40(1):82-8. doi: 10.1007/s001250050646.
3
The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes.餐时普兰林肽在1型糖尿病青少年患者治疗中的作用。
Pediatr Res. 2007 Dec;62(6):746-9. doi: 10.1203/PDR.0b013e318159af8c.
4
Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects.低剂量普兰林肽可减少健康正常体重受试者的食物摄入量和进餐时间。
Obesity (Silver Spring). 2007 May;15(5):1179-86. doi: 10.1038/oby.2007.626.
5
Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.在2型糖尿病患者中,与赖脯胰岛素联合使用时,普兰林肽可减少餐后血糖波动:一项剂量-给药时间研究。
Diabetes Metab Res Rev. 2004 Jan-Feb;20(1):55-60. doi: 10.1002/dmrr.419.
6
Pramlintide lowered glucose excursions and was well-tolerated in adolescents with type 1 diabetes: results from a randomized, single-blind, placebo-controlled, crossover study.普兰林肽可降低1型糖尿病青少年的血糖波动,且耐受性良好:一项随机、单盲、安慰剂对照、交叉研究的结果
J Pediatr. 2009 Sep;155(3):369-73. doi: 10.1016/j.jpeds.2009.03.012. Epub 2009 May 21.
7
Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus.胰淀素类似物普兰林肽对1型和2型糖尿病患者胃排空的影响。
Neurogastroenterol Motil. 2002 Apr;14(2):123-31. doi: 10.1046/j.1365-2982.2002.00311.x.
8
Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.人胰淀素类似物普兰林肽(AC137)皮下注射14天对胰岛素依赖型糖尿病患者静脉注射胰岛素激发试验及标准流食餐反应的影响。
Diabetologia. 1996 Apr;39(4):492-9. doi: 10.1007/BF00400683.
9
Effect of euglycaemic hyperinsulinaemia on gastric emptying and gastrointestinal hormone responses in normal subjects.正常受试者中正常血糖高胰岛素血症对胃排空及胃肠激素反应的影响。
Diabetologia. 1998 Apr;41(4):474-81. doi: 10.1007/s001250050932.
10
Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.醋酸普兰林肽注射液用于治疗1型和2型糖尿病。
Clin Ther. 2007 Apr;29(4):535-62. doi: 10.1016/j.clinthera.2007.04.005.

引用本文的文献

1
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).成人 1 型糖尿病管理。美国糖尿病协会 (ADA) 和欧洲糖尿病研究协会 (EASD) 的共识报告。
Diabetologia. 2021 Dec;64(12):2609-2652. doi: 10.1007/s00125-021-05568-3.
2
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases.胰淀素、降钙素和 CGRP 受体的单激动剂和双激动剂及其在代谢性疾病中的潜在作用。
Mol Metab. 2021 Apr;46:101109. doi: 10.1016/j.molmet.2020.101109. Epub 2020 Nov 7.
3
Diabetic Gastroparesis and Glycaemic Control.
糖尿病性胃轻瘫与血糖控制。
Curr Diab Rep. 2019 Dec 2;19(12):153. doi: 10.1007/s11892-019-1281-8.
4
Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes.用于开发针对与2型糖尿病相关的胰岛淀粉样多肽聚集的蛋白水解稳定的N-甲基化肽抑制剂。
Interface Focus. 2017 Dec 6;7(6):20160127. doi: 10.1098/rsfs.2016.0127. Epub 2017 Oct 20.
5
Update on the treatment of type 2 diabetes mellitus.2型糖尿病治疗的最新进展
World J Diabetes. 2016 Sep 15;7(17):354-95. doi: 10.4239/wjd.v7.i17.354.
6
Amylin-mediated control of glycemia, energy balance, and cognition.胰淀素介导的血糖、能量平衡及认知调控。
Physiol Behav. 2016 Aug 1;162:130-40. doi: 10.1016/j.physbeh.2016.02.034. Epub 2016 Feb 27.
7
Treating the elderly diabetic patient: special considerations.治疗老年糖尿病患者:特殊考虑因素。
Diabetes Metab Syndr Obes. 2014 Aug 28;7:391-400. doi: 10.2147/DMSO.S48898. eCollection 2014.
8
Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function.胃排空延迟对餐后血糖动力学、胰岛素敏感性和β细胞功能的影响。
Am J Physiol Endocrinol Metab. 2014 Sep 15;307(6):E494-502. doi: 10.1152/ajpendo.00199.2014. Epub 2014 Jul 29.
9
A model of glucose-insulin-pramlintide pharmacokinetics and pharmacodynamics in type I diabetes.I型糖尿病中葡萄糖-胰岛素-普兰林肽的药代动力学和药效学模型。
J Diabetes Sci Technol. 2014 May;8(3):529-42. doi: 10.1177/1932296813517323. Epub 2014 Feb 9.
10
In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes.1 型糖尿病中美他瑞林与胰岛素联合给药最优比例的计算机设计。
Diabetes Technol Ther. 2013 Oct;15(10):802-9. doi: 10.1089/dia.2013.0054. Epub 2013 Jul 18.